181
Registered trials
49
Recruiting
121
Completed trials
85
Sponsors active
39
Research sites
Phase III:
132
Phase II/III:
7
Phase II:
29
Phase I/II:
2
Phase III/IV:
1
Phase IV:
6
Phase I (Other):
1
Phase I (FiH):
2
Other:
1
Oversight events in trials active here:
24 serious breaches
64 temporary halts
1 urgent safety measure
6 unexpected events
2 corrective measures
across 28 trials
View oversight register →
Top conditions
Non-small cell lung cancer
5
Rheumatoid arthritis
4
Atrial fibrillation
3
Relapsing multiple sclerosis
3
Influenza
2
Multiple sclerosis
2
Non-small cell lung cancer stage II
2
Colitis ulcerative
2
Secondary progressive multiple sclerosis
2
Non-small cell lung cancer metastatic
2
Pneumococcal immunisation
2
Primary progressive multiple sclerosis
2
Top sponsors
Merck Sharp & Dohme LLC
15
Novartis Pharma AG
12
AbbVie Deutschland GmbH & Co. KG
10
Amgen Inc.
7
GlaxoSmithKline Biologicals
6
Janssen - Cilag International
6
Argenx
5
F. Hoffmann-La Roche AG
5
Turku University Hospital
5
AstraZeneca AB
4
Boehringer Ingelheim Espana S.A.
4
Boehringer Ingelheim International GmbH
4
Cities with most trials
All 15 cities →All trials — page 2
181 totalShowing 25–48 of 181 trials